2 completed, 1 recruiting, 1 terminated. 4 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Mitochondrial Myopathies: new trials by email Literature Review of Mitochondrial Myopathies trials Research Report on Mitochondrial Myopathies
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases Sonlicromanol, Placebo - Mitochondrial Diseases, Maternally Inherited Diabetes and Deafness (MIDD) | Phase 3 | Recruiting | Khondrion BV | 220 | 2026-04-14 | 2026-10-14 |
| A Safety Study for Previously Treated Vatiquinone (PTC743) Participants With Inherited Mitochondrial Disease Vatiquinone - Inherited Mitochondrial Disease | Phase 3 | Completed | PTC Therapeutics | 101 | 2022-06-22 | 2025-12-22 |
| Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) Elamipretide, Placebo - Mitochondrial Myopathies, Mitochondrial Pathology | Phase 3 | Completed | Stealth BioTherapeutics Inc. | 102 | 2022-04-29 | 2025-10-24 |
| A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy Vatiquinone, Placebo - Mitochondrial Diseases, Drug Resistant Epilepsy | Phase 2 / Phase 3 | Terminated | PTC Therapeutics | 68 | 2020-09-28 | 2026-03-31 |
MELAS Syndrome (3) · Mitochondrial Diseases (3) · Diffuse Cerebral Sclerosis of Schilder (2) · Drug Resistant Epilepsy (2) · Leigh Disease (2) · MERRF Syndrome (2) · Mitochondrial Encephalomyopathies (1) · Mitochondrial complex I deficiency (1) · Mitochondrial encephalopathy (1) · Muscle Weakness (1) · Nerve Degeneration (1) · Noninsulin-dependent diabetes mellitus with deafness (1) · Ophthalmoplegia, Chronic Progressive External (1) · Pontocerebellar Hypoplasia Type 6 (1)
Metabolic Diseases (4) · Muscular Diseases (4) · Musculoskeletal Diseases (4) · Nervous System Diseases (4) · Neuromuscular Diseases (4) · Nutritional and Metabolic Diseases (4) · Brain Diseases (3) · Brain Diseases, Metabolic (3) · Brain Diseases, Metabolic, Inborn (3) · Cardiovascular Diseases (3) · Central Nervous System Diseases (3) · Cerebral Small Vessel Diseases (3) · Cerebrovascular Disorders (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Genetic Diseases, Inborn (3)
alpha-tocotrienol quinone (2) · arginyl-2,'6'-dimethyltyrosyl-lysyl-phenylalaninamide (1)
PTC Therapeutics (2) · Khondrion BV (1) · Stealth BioTherapeutics Inc. (1)
Italy (4) · United Kingdom (4) · United States (4) · France (3) · Spain (3) · Germany (2) · Japan (2) · Netherlands (2) · Poland (2) · Australia (1) · Canada (1) · Denmark (1) · Hungary (1) · New Zealand (1) · Norway (1)